Is complement a target for therapy in renal disease?

Slides:

Advertisements

Similar presentations

Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis Giuseppe D’Amico Kidney International Volume 54, Issue 2, Pages

Advertisements

Epidemiology of end-stage renal disease: International comparisons of renal replacement therapy Francesco Paolo Schena Kidney International Volume 57,

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.

Melamine toxicity: one more culprit in calcium kidney lithiasis

Intensive hemodialysis—keeping the faith

Volume 78, Issue 2, Pages (July 2010)

Mitchell H. Rosner, W. Kline Bolton Kidney International

End-stage renal disease in developing countries

Volume 83, Issue 3, Pages (March 2013)

Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure Steven Fishbane, Nobuyuki Miyawaki Kidney International

Takehiko Wada, Masaomi Nangaku Kidney International

ESA and iron therapy in chronic kidney disease: a balance between patient safety and hemoglobin target Szu-Chun Hung, Der-Cherng Tarng Kidney International

Subclinical rejection in renal transplants is associated with low serum mannose-binding lectin levels Meritxell Ibernon, Francesc Moreso, Daniel Serón

Innate immunity as a driving force in renal disease

Intensive hemodialysis—keeping the faith

Continuous renal replacement therapy in the critically ill patient

Volume 80, Issue 10, Pages (November 2011)

Progression of renal failure and hypertensive nephrosclerosis

Section 5: Dialysis Interventions for Treatment of AKI

Volume 77, Issue 1, Pages 6-8 (January 2010)

Burden of chronic kidney disease: North Africa

Need for better diabetes treatment for improved renal outcome

Volume 58, Issue 1, Pages (July 2000)

Comorbidity and confounding in end-stage renal disease

Volume 74, Issue 3, Pages (August 2008)

Punit Yadav, Nelson Leung, Paul W. Sanders, Paul Cockwell

Volume 70, Issue 11, Pages (December 2006)

Pieter Evenepoel, Björn K. Meijers Kidney International

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 12, Pages (December 2006)

Melamine toxicity: one more culprit in calcium kidney lithiasis

Volume 59, Issue 4, Pages (April 2001)

Fructose intake as a risk factor for kidney stone disease

Response to ‘Hepcidin levels in patients with renal disease’

Volume 76, Issue 6, Pages (September 2009)

Volume 87, Issue 1, Pages (January 2015)

Extracorporeal therapy in sepsis: are we there yet?

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Presentation of the 2003 Jean Hamburger Award to Robert W. Schrier

Methods for guideline development

Volume 87, Issue 1, Pages (January 2015)

The global challenge of chronic kidney disease

Nephrology Crossword: Glomerulonephritis

V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Unilateral renal cystic disease

Volume 73, Issue 9, Pages (May 2008)

Volume 82, Issue 9, Pages (November 2012)

Peter G. Blake, Arsh K. Jain, Sechelle Yohanna Kidney International

Organ transplantation goes to the movies

Does equal care give equal outcomes?

Volume 80, Issue 10, Pages (November 2011)

Volume 64, Issue 5, Pages (November 2003)

Is it the low-protein diet or simply the salt restriction?

Volume 70, Issue 3, Pages (August 2006)

Tobias Breidthardt, Alexandre Mebazaa, Christian E. Mueller

Volume 75, Issue 7, Pages (April 2009)

Hisataka Kobayashi, Peter L. Choyke Kidney International

The conundrum of increased burden of end-stage renal disease in Asians

Volume 70, Issue 10, Pages (November 2006)

In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression B.O. Eriksen, O.C. Ingebretsen Kidney.

Abby S. Kazley, Kit N. Simpson, Kenneth D. Chavin, Prabhakar Baliga

Familial phenotype differences in PKD11

Volume 74, Issue 10, Pages (November 2008)

Volume 56, Issue 6, Pages (December 1999)

Asymmetric dimethylarginine: A cardiovascular risk factor in renal disease? Danilo Fliser, Jan T. Kielstein, Hermann Haller, Stefanie M. Bode-Böger Kidney.

Ronen Levi, Justin Silver Kidney International

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Presentation transcript:

Is complement a target for therapy in renal disease? Peter W. Mathieson Kidney International Volume 54, Issue 5, Pages 1429-1436 (November 1998) DOI: 10.1046/j.1523-1755.1998.00129.x Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 1 Overview of the complement system showing the three pathways (classical, alternative and lectin) that converge on a common terminal pathway. Kidney International 1998 54, 1429-1436DOI: (10.1046/j.1523-1755.1998.00129.x) Copyright © 1998 International Society of Nephrology Terms and Conditions